There are no proven peptides for autism. The most studied peptide, oxytocin nasal spray, failed in the largest trial: in SOARS-B, 290 children and teens improved about equally on oxytocin and placebo over 24 weeks.[1] Secretin, a gut peptide once widely given to autistic children, showed no benefit in more than 900 children across randomized trials.[5] Peptides sold online for autism, such as BPC-157 or Semax, have not been tested in autistic children at all.
This guide covers what has been tested and what hasn’t. For the broader topic, see our nootropic peptides hub.
Evidence at a glance
| Peptide or treatment | Evidence level | What was shown | FDA status | Our profile |
|---|---|---|---|---|
| Risperidone, aripiprazole | FDA-approved for this use (irritability only) | Approved for irritability with autism in children and teens[7][8] | Approved (not peptides) | n/a |
| Behavioral and developmental therapies | Human RCTs | Growing evidence for specific skills[6] | Not drugs | n/a |
| Oxytocin (nasal) | Human RCTs | No benefit in SOARS-B; mixed smaller trials[1][2] | Approved only as an injection for labor and postpartum bleeding[10] | Oxytocin |
| Secretin | Human RCTs | No benefit for core features[5] | Not approved for autism | n/a |
| BPC-157, Semax, Selank, others | No evidence, marketing only | No autism studies | Not approved | BPC-157, Semax, Selank |
Start with what works
The American Academy of Pediatrics recommends screening at 18 and 24 months, early diagnosis and evidence-based behavioral and developmental interventions that target specific skills. It also calls for treating co-occurring problems such as sleep, gut symptoms, anxiety, seizures and ADHD, and for shared decision-making with families.[6]
No medicine treats the core features of autism. Two medicines are FDA-approved for irritability linked to autism, such as aggression, self-injury and severe tantrums: risperidone for ages 5 to 16 and aripiprazole for ages 6 to 17.[7][8] Both have side effects, including weight gain, that a clinician monitors.
Oxytocin: promising early, negative in the largest trial
Oxytocin is a hormone involved in bonding and social behavior, which made it a natural candidate.
- Early crossover trial (2016): 31 young children received oxytocin and placebo nasal spray for 5 weeks each. Caregiver-rated social responsiveness improved on oxytocin. Thirst, urination and constipation were the most common side effects.[3]
- SOARS-B (NEJM, 2021): this US government-funded phase 2 trial enrolled 290 children and teens aged 3 to 17. After 24 weeks of nasal oxytocin (target 48 units daily) or placebo, the main social-withdrawal score improved by 3.7 points on oxytocin and 3.5 on placebo, a difference that was not significant. Secondary social and IQ measures also did not differ. Side effects were similar in both groups.[1]
- Australian trial (2023): 87 children aged 3 to 12 used oxytocin or placebo for 12 weeks. There was no overall benefit. An age interaction suggested some caregiver-rated improvement in children aged 3 to 5, but clinician ratings and secondary measures showed no benefit.[2]
The SOARS-B authors noted that oxytocin had already been given in clinical practice to many autistic children before their trial.[1] Short-term nasal oxytocin has had few side effects in controlled research,[11] but no approved nasal product is sold in the US, and long-term effects in children are not well studied.
Secretin: a cautionary tale
Secretin is a gut hormone that stimulates the pancreas. In 1998, reports of a child who seemed to improve after a secretin dose spread quickly, and thousands of autistic children may have received injections.[4]
- First controlled trial (NEJM, 1999): in 60 children, a single IV dose of secretin did no better than saline. Behavior scores actually improved more on placebo. Even after hearing the results, 69% of parents said they were still interested in secretin.[4]
- Cochrane review (2012): 16 randomized trials with more than 900 children found no improvement in core autism features. The authors concluded secretin should not be recommended or given as a treatment.[5]
Secretin shows how a peptide can become popular on anecdotes and then fail when properly tested.
Other peptides marketed for autism
Online, peptides such as BPC-157, Semax, Selank and Dihexa are sometimes promoted for autism, often with claims about the gut-brain connection, “neuroinflammation” or brain growth factors. None of these claims comes from autism trials.
- BPC-157 is promoted for gut healing. Its human evidence in any condition is very thin, and none involves children. See BPC-157 clinical trials.
- Semax and Selank are Russian nasal peptides studied mainly in adults with stroke or anxiety. See Selank vs Semax.
- Dihexa has only rat data and no human safety data at all. See Dihexa vs Semax vs Selank.
Many autistic children do have gut symptoms, sleep problems or anxiety. These deserve real medical attention, and a pediatrician can treat them with approaches that have been tested.[6]
Why caution matters for children
- Untested in children: most peptides sold online have never been studied in any children, so doses and long-term effects are unknown.
- Unregulated products: research peptides are not checked for purity, sterility or dose.
- Injections and infusions: some unproven autism treatments involve needles or IV lines, which carry infection and other risks.
- Opportunity cost: money and time spent on unproven products can delay therapies with evidence behind them.
- Fraud warnings: FDA states that unproven products claiming to treat autism are misleading and deceptive.[9]
Questions to ask your child’s care team
- Which therapies have evidence for my child’s specific needs?
- Are there clinical trials my child could join safely?
- Could this product interact with my child’s current medicines?
For related guides, see peptides for ADHD, best peptides for anxiety and peptide nasal spray vs injection.
